Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID02097758

Efficacy of Three-Dimensional Transesophageal Echocardiography for Device Closure of Atrial Septal Defect

Led by Asan Medical Center · Updated on 2025-02-07

100

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying the use of three-dimensional transesophageal echocardiography to select the correct device size for closing atrial septal defects (ASD) without using a sizing balloon. The study aims to confirm the accuracy of a previously developed formula for device size prediction and improve the procedure for ASD patients. This research is sponsored by Asan Medical Center and focuses on patients aged 18 to 80 who are candidates for device closure. Participants undergo transcatheter device closure where the device size is chosen using the three-dimensional echocardiographic images combined with the formula, avoiding the use of a sizing balloon. This method is being evaluated for its effectiveness in ensuring successful device implantation during the procedure. During the study, researchers will measure the success of device implantation within one day after the procedure and record procedure time. Participants will be monitored closely to assess outcomes related to the device closure process. The study started in March 2014 and is expected to continue until December 2026, involving adult patients who meet the eligibility criteria.

CONDITIONS

Brief Title

Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Indication for atrial septal defect closure
  • Potential candidate for device closure
Not Eligible

You will not qualify if you...

  • Poor candidate for device closure, such as having multiple atrial septal defects
  • Presence of other heart diseases requiring open heart surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Implementation

Duration - Procedure day

Participants undergo transcatheter device closure of the atrial septal defect using three-dimensional imaging to select device size without a sizing balloon.

1 procedure visit (in-person)

Trial Site Locations

Total: 1 location

1

Asan Medical Center

Seoul, South Korea, 138-736

Actively Recruiting

Loading map...

Research Team

J

Jong-Min Song, MD,PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

Cera153 ASD Occluder Post-Market Clinical Follow-Up Study: ...

Atrial Septal Defect

Actively Recruiting

6 locations

De Novo Cerebral Microembolization Associated With Patent Fo...

Thrombosis Cardiac

Actively Recruiting

1 location

A Multi-center, Single-arm, Real-world Registry Assessing th...

Atrial Septal Defect

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Routine application of three-dimensional transesophageal echocardiography-based device selection for transcatheter closure of atrial septal defect without balloon sizing.

Pil Hyung Lee, Ga Yun Kim, Jae Sung Yu...

https://pubmed.ncbi.nlm.nih.gov/41530892

Efficacy of 3D transoesophageal echocardiography for transcatheter device closure of atrial septal defect without balloon sizing.

Jeong Yoon Jang, Ran Heo, Min Soo Cho...

https://pubmed.ncbi.nlm.nih.gov/28633478